XBiotech Inc. (XBIT) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
XBIT Revenue Growth
Revenue Breakdown (FY 2022)
XBIT's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
XBIT Revenue Analysis (2013–2024)
As of May 8, 2026, XBiotech Inc. (XBIT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, XBIT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $44.0 million in 2020.
Revenue diversification analysis shows XBIT's business is primarily driven by Manufacturing Revenue (100%), and Clinical Trial Service Revenue (0%). With over half of revenue concentrated in Manufacturing Revenue, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including RCUS (+67.4% YoY), ARQT (+95.3% YoY), and DAWN (+20.6% YoY). Compare XBIT vs RCUS →
XBIT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XBITCurrent | $0 | - | - | - | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 DAWN | $158M | +20.6% | - | -80.8% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% |
XBIT Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-42,471,000 | - |
| 2023 | $0 | -100.0% | $0 | - | $-37,510,000 | - |
| 2022 | $4.0M | -78.2% | $3.4M | 83.8% | $-34,490,000 | -860.1% |
| 2021 | $18.4M | -58.2% | $12.6M | 68.4% | $-25,082,000 | -136.4% |
| 2020 | $44.0M | - | $9.4M | 21.5% | $-18,276,000 | -41.5% |
| 2019 | $0 | - | $-2,361,000 | - | $-31,233,000 | - |
| 2018 | $0 | - | $-2,433,000 | - | $-20,994,000 | - |
| 2017 | $0 | - | $-1,484,000 | - | $-34,059,000 | - |
| 2016 | $0 | - | $-698,000 | - | $-52,763,000 | - |
| 2015 | $0 | - | $-699,000 | - | $-37,510,000 | - |
See XBIT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XBIT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XBIT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXBIT — Frequently Asked Questions
Quick answers to the most common questions about buying XBIT stock.
Is XBIT's revenue growth accelerating or slowing?
XBIT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is XBIT's long-term revenue growth rate?
XBiotech Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is XBIT's revenue distributed by segment?
XBIT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.